This Monday morning session was arranged by Michael E. Swartz, of Synomics Pharmaceutical Services (Wareham, Massachusetts). Unfortunately, Swartz was unable to preside over the session or deliver a presentation as planned due to a cancelled flight to Chicago. Ken Fountain of Waters Corporation (Milford, Massachusetts) filled in ably for Swartz in presiding over the session.
This Monday morning session was arranged by Michael E. Swartz, of Synomics Pharmaceutical Services (Wareham, Massachusetts). Unfortunately, Swartz was unable to preside over the session or deliver a presentation as planned due to a cancelled flight to Chicago. Ken Fountain of Waters Corporation (Milford, Massachusetts) filled in ably for Swartz in presiding over the session.
Chromatography with sub-2-µm particles currently is a hot topic in separation science because of its potential for high resolution separations and reduced solvent consumption. Many instrument manufacturers have focused their efforts on this area.
The session began with a presentation by Ken Fountain titled “Achieving Maximum Performance with Sub-2-µm Particles.” The presentation focused on the effects of system volume, operating pressure, and separation temperature on separations using sub-2-µm particle columns.
Richard Verseput of S-Matrix (Eureka, California) presented a talk titled “A Quality-by-Design Methodology for Rapid LC Method Development.” Verseput’s presentation described an approach for the development of robust LC methods. The goal of the approach is to accelerate the column screening process and identify optimum LC instrument settings.
A presentation given by Rachel A. Lieberman of the University of North Carolina at Chapel Hill was titled “Investigations of Column Packing Technology Using 1.0-µm Bridged Ethyl Hybrid Particles in Ultrahigh-Pressure Liquid Chromatography.” The bridged ethyl hybrid particles were suspended in acetone, tetrahydrofuran, and methyl ethyl ketone, and the effects of the various solvents on column packing and performance were investigated.
After a brief recess, Michael W. Dong of Genentech (South San Francisco, California) presented a talk titled “Potential Issues of Ultrahigh-Pressure LC Using Sub-2-µm Columns in Regulated Analysis.” His talk focused on various areas of concern in using sub-2-µm columns, including safety issues, compatibility with conventional columns and methods, injection precision and carryover, detector sensitivity, and system reliability and ease of use.
Mark Jacyno of Grace Davison Discovery Sciences (Deerfield, Illinois) then presented “Ultrahigh-Pressure LC Selectivity Options for High-Speed Separations.” Jacyno’s talk described and discussed the use of various sub-2-µm phases with complementary selectivities for pharmaceutical, environmental, and biotech applications.
The penultimate presentation in the session was titled “Using Fused-Core Particle Technology to Achieve Near Sub-2-µm Performance Using Conventional HPLC Equipment” and was presented by Thomas Waeghe of MAC-MOD Analytical (Chadds Ford, Pennsylvania). The presentation discussed research conducted using the company’s Fused-Core particles and HALO columns.
The session’s final presentation was given by Frank Dorman of Restek Corporation (Bellefonte, Pennsylvania) and was titled “The Role and Importance of Particle Dimensions and Stationary Phase Chemistry for Silica-Based UHPLC Columns.” In his presentation, Dorman discussed the effects of particle size, particle size distribution, and stationary phase selectivity on performance and column selection.
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.